Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Inflammation × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 11 Cancer Pain 11 Pain 8 Pain, Postoperative 5 Agnosia 4 Colonic Neoplasms 3 Neoplastic Cells, Circulating 2 Mucositis 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Colorectal Neoplasms 2 Chronic Pain 2 Breakthrough Pain 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Signs and Symptoms 1 Sezary Syndrome 1 Reperfusion Injury 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Polycythemia Vera 1

Interventions

Exercise 5 Vitamin D 2 Tea 2 Sufentanil 2 Spironolactone 2 Oxycodone 2 Omeprazole 2 Metformin 2 Etanercept 2 Colchicine 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 salicylsalicylic acid 1 ginger extract 1 falcarinol 1 falcarindiol 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Sulindac 1 Sodium Salicylate 1 Sevoflurane 1 Sevelamer 1 Rocuronium 1 Riluzole 1 Resistance Training 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡